Evidence map›Paper›PMID 30225768›Full record

ReviewJournal of general internal medicine2018

Diagnosis and Management of Genetic Iron Overload Disorders.

William C Palmer, Prakash Vishnu, William Sanchez, Bashar Aqel, Doug Riegert-Johnson, Leigh Ann Kenda Seaman, Andrew W Bowman, Candido E Rivera

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of general internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 45 citations in OpenAlex.

  1. Iron Overload: Pathophysiology, Diagnosis and Monitoring.International journal of laboratory hematology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Iron Dysregulation in Cardiovascular Diseases.Reviews in cardiovascular medicine · 2024
    Review
  13. Article
  14. Review
  15. Liver Iron Loading in Alcohol-Associated Liver Disease.The American journal of pathology · 2023
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

William C PalmerDepartment of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA. Palmer.william@mayo.edu.
Prakash VishnuDepartment of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA.
William SanchezDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Bashar AqelDepartment of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, USA.
Doug Riegert-JohnsonDepartment of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Leigh Ann Kenda SeamanDepartment of Nutrition, Mayo Clinic, Jacksonville, FL, USA.
Andrew W BowmanDepartment of Radiology, Mayo Clinic, Jacksonville, FL, USA.
Candido E RiveraDepartment of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA.
Mayo Clinic in Florida · USMayo Clinic in Arizona · USWinnMed · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron overload disorders lead to excess iron deposition in the body, which can occur as a result of genetic or secondary causes. Genetic iron overload, referred to as hereditary hemochromatosis, may present as a common autosomal recessive mutation or as one of several uncommon mutations. Secondary iron overload may result from frequent blood transfusions, exogenous iron intake, or certain hematological diseases such as dyserythropoietic syndrome or chronic hemolytic anemia. Iron overload may be asymptomatic, or may present with significant diseases of the liver, heart, endocrine glands, joints, or other organs. If treated appropriately prior to end-organ damage, life expectancy has been shown to be similar compared to matched populations. Alongside clinical assessment, diagnostic studies involve blood tests, imaging, and in some cases liver biopsy. The mainstay of therapy is periodic phlebotomy, although oral chelation is an option for selected patients.

Indexed as

Disease ManagementHemochromatosisHumansIron OverloadMutationhemochromatosisiron overload

Identifiers

PMID30225768
PMCPMC6258594
OpenAlexW2891708430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.